In addition, gp130 predicted HNSCC-specific survival (p = 0.045), whereas IL6Rα (p = 0.066) and IL31 (p = 0.052) were indicated by borderline trend results (Figure 5). Here, IL31 is linked to head and neck squamous cell carcinoma.